1. Home
  2. ULY vs NKGN Comparison

ULY vs NKGN Comparison

Compare ULY & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULY
  • NKGN
  • Stock Information
  • Founded
  • ULY 2013
  • NKGN 2017
  • Country
  • ULY United States
  • NKGN United States
  • Employees
  • ULY N/A
  • NKGN N/A
  • Industry
  • ULY
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ULY
  • NKGN Health Care
  • Exchange
  • ULY Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • ULY 7.2M
  • NKGN 14.1M
  • IPO Year
  • ULY N/A
  • NKGN N/A
  • Fundamental
  • Price
  • ULY $0.50
  • NKGN $0.65
  • Analyst Decision
  • ULY Strong Buy
  • NKGN
  • Analyst Count
  • ULY 1
  • NKGN 0
  • Target Price
  • ULY $1.50
  • NKGN N/A
  • AVG Volume (30 Days)
  • ULY 90.0K
  • NKGN 570.0K
  • Earning Date
  • ULY 11-12-2024
  • NKGN 12-24-2024
  • Dividend Yield
  • ULY N/A
  • NKGN N/A
  • EPS Growth
  • ULY N/A
  • NKGN N/A
  • EPS
  • ULY 7.18
  • NKGN N/A
  • Revenue
  • ULY $155,926,000.00
  • NKGN N/A
  • Revenue This Year
  • ULY N/A
  • NKGN N/A
  • Revenue Next Year
  • ULY $20.40
  • NKGN N/A
  • P/E Ratio
  • ULY $0.07
  • NKGN N/A
  • Revenue Growth
  • ULY N/A
  • NKGN N/A
  • 52 Week Low
  • ULY $0.41
  • NKGN $0.20
  • 52 Week High
  • ULY $3.45
  • NKGN $4.06
  • Technical
  • Relative Strength Index (RSI)
  • ULY 33.74
  • NKGN 65.93
  • Support Level
  • ULY $0.46
  • NKGN $0.45
  • Resistance Level
  • ULY $0.58
  • NKGN $0.62
  • Average True Range (ATR)
  • ULY 0.06
  • NKGN 0.08
  • MACD
  • ULY -0.00
  • NKGN 0.01
  • Stochastic Oscillator
  • ULY 0.00
  • NKGN 70.95

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and lead to long wait times. Urgently offers an innovative alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: